DRADS Capital is a Boston-based venture fund investing in life sciences, biotechnology, and A.I. companies focused on extending the boundaries of biomedical sciences. Our unique approach merges breakthrough science and technology from top academic laboratories and hospitals with strong leadership teams that are transforming how we treat and improve neurological health. Our portfolio of companies are unlocking human potential in treating neurodegenerative disease, improving mind-body wellness, and quantifying brain health.
Company Details
- Employees
- 7
- Founded
- 2018
- Address
- 245 Main St,
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- dradscapital.com
- Keywords
- Cambridge.
- HQ
- Cambridge, Massachusetts
Drads Capital Questions
Drads Capital's website is dradscapital.com
Drads Capital's LinkedIn profile is https://www.linkedin.com/company/dradscapital
Drads Capital has
7 employees.
View email and phone details for 7
employees at Drads Capital.
Drads Capital's industry is
Venture Capital and Private Equity Principals
Drads Capital's top competitors are
Varshney Capital Corp.,
Voxcell Bioinnovation,
Taktile,
Onfield,
React Neuro,
Eupraxia Pharmaceuticals Inc.,
Dayli Venture Capital,
Alsym Energy,
Industrial Plankton Inc.,
Symmetrylearningsystems.
Drads Capital's categories are Venture Capital and Private Equity Principals
Drads Capital's founding year is 2018
